Michael Scolaro

Michael Scolaro

Nov 19, 2017

Group 6 Copy 204
1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Brrr…It’s Cold! Can Blood Nanovesicles Encourage Heat Production and Help Fight Obesity?

Exosomes are cell derived nanovesicles found in all body fluids that mediate intercellular communication...

Can personalized medicine subtype bladder cancer?

Molecular pathoepidemiology is the study of the cause and natural history of disease on a molecular, individual...

Can a rabies vaccination booster save African Wild Dogs?

Rabies is one of the greatest threats to the continued survival of the African wild dog (Lycaon pictus...

Backer Badge Funded